Research Article

Receptor Guided 3D-QSAR: A Useful Approach for Designing of IGF-1R Inhibitors

Table 1

The structures and observed IGF inhibitory activities [15].

No.StructureRIC50 (M)pIC50

1A4-OBn 5.706
2A3-OH 6.286
3A3-OBn–4-OMe 5.870
4A3-OBn–4-OH 5.480
5*BCyclopentyl 5.456
6BCyclohexyl 5.979
7*B–CH2–cyclopropyl 5.644
8*B–CH2–cyclohexyl 5.955
9B–CH2CH2OMe 5.202
10B–CH2–2-pyridyl 5.963
11CH 6.218
12C2-F 6.650
13C3-F 6.292
14C4-F 5.910
15C2-Cl 6.465
16C3-Cl 5.674
17*C4-Cl0.980 6.009
18C2-OCF2H3.28 5.484
19C3-OCF2H5.78 5.238
20C4-OCF2H2.82 5.550
21C2,3-Difluoro0.898 6.047
22C3,4-Difluoro4.48 5.349
23*C2,5-Difluoro0.329 6.483
24C2,6-Difluoro0.215 6.668
25C3,5-Difluoro1.35 5.870
26C2,6-Dichloro1.67 5.777
27C2-Cl,6-F0.248 6.606
28DCyclopentyl1.05 5.979
29DCyclohexyl3.51 5.455
30DCycloheptyl3.79 5.421
31*DPhenyl1.68 5.775
32Etrans-NH20.221 6.656
33Ecis-NH20.775 6.111
34*Etrans-NHMe0.105 6.979
35Etrans-Pyrrolodinyl1.82 5.740
36*Etrans-Piperidinyl3.40 5.469
37Etrans-NHPh1.30 5.886
38Etrans-NHBn1.39 5.857
39Ftrans-NH20.119 6.924
40Fcis-NH20.228 6.642
41Ftrans-N(Et)20.115 6.939
42Ftrans-Azetidinyl0.081 7.092
43Ftrans-Pyrrolidinyl0.103 6.987
44*Ftrans-Morpholino0.091 7.041
45*Gtrans-Pyrrolidinyl0.116 6.936
46Gcis-Pyrrolidinyl0.089 7.051
47Gcis-NH20.060 7.222
48Gcis-NMe20.166 6.780
49*Gcis-Piperidinyl0.237 6.625
50Gcis-Morpholino0.148 6.830
51Gcis-NH-iPr0.220 6.658
52Gcis-N(Me)-Piperizinyl0.265 6.577
53Htrans-NH20.526 6.279
54Hcis-NH20.554 6.256


* Compounds used in the test set.